HTG Molecular Diagnostics (STU:65H) Forward Dividend Yield % : 0.00% (As of Jun. 08, 2024)

View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Forward Dividend Yield %?

As of today (2024-06-08), the Forward Annual Dividend Yield of HTG Molecular Diagnostics is 0.00%.

As of today (2024-06-08), the Trailing Annual Dividend Yield of HTG Molecular Diagnostics is 0.00%.

STU:65H's Forward Dividend Yield % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.45
* Ranked among companies with meaningful Forward Dividend Yield % only.

HTG Molecular Diagnostics's Dividends per Share for the three months ended in Mar. 2023 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of HTG Molecular Diagnostics's Forward Dividend Yield %

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Forward Dividend Yield % falls into.

HTG Molecular Diagnostics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

HTG Molecular Diagnostics (STU:65H) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

HTG Molecular Diagnostics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (STU:65H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

HTGMQ:USA

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines